Developed by Otsuka Pharmaceutical , the Ability MyCite pill contains Arpiprazole, a drug that has been approved in the United States for years, and a sensor by Proteus Digital that responds to gastric acid.
After the patient has swallowed the pill, the sensor sends a signal to a patch which forwards the information to a smartphone app. Depending on the configuration, nurses and doctors can be informed that the pill has been taken.
Experts expect digitization to fundamentally change modern medicine in the fields of diagnosis and therapy over the next few years. A survey conducted by the digital association BITKOM last year shows that patients are quite positive about this. For example, 6 out of 10 Germans claim that they would be willing to be operated on by a robot, or could at least imagine it.
One out of four would also take smart tablets like the digital pill now approved for use in the United States.